A detailed history of Tcg Crossover Management, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 1,423,642 shares of KURA stock, worth $11.3 Million. This represents 3.61% of its overall portfolio holdings.

Number of Shares
1,423,642
Previous 1,423,642 -0.0%
Holding current value
$11.3 Million
Previous $29.3 Million 5.1%
% of portfolio
3.61%
Previous 4.39%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$11.23 - $16.9 $842,250 - $1.27 Million
75,000 Added 5.56%
1,423,642 $17.7 Million
Q3 2022

Nov 14, 2022

BUY
$12.01 - $19.45 $2.17 Million - $3.52 Million
181,000 Added 15.5%
1,348,642 $18.4 Million
Q2 2022

Aug 15, 2022

BUY
$10.71 - $18.33 $7.08 Million - $12.1 Million
661,219 Added 130.57%
1,167,642 $21.4 Million
Q1 2022

May 16, 2022

BUY
$11.78 - $16.98 $5.97 Million - $8.6 Million
506,423 New
506,423 $8.14 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $529M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Tcg Crossover Management, LLC Portfolio

Follow Tcg Crossover Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Crossover Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Crossover Management, LLC with notifications on news.